FIELD: medicine.
SUBSTANCE: group of inventions is related to a drug for the treatment of T3 cervical cancer and a method for the treatment of T3 cervical cancer. A drug for the treatment of T3 cervical cancer, which is a solution of formaldehyde in 0.9 wt.% isotonic sodium chloride solution for injection, with the following ratio of components: formaldehyde - 0.012 wt.%, 0.9 wt.% isotonic sodium chloride solution for injection - the rest. A method of treating T3 cervical cancer, including intramuscular administration of the above drug in an amount of 2 ml once a day during the period from diagnosis until the complete disappearance of metastases and then 20 months, 2 ml once every five days.
EFFECT: group of inventions makes it possible to expand the arsenal of drugs for the treatment of T3 cervical cancer.
2 cl, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTITUMOR AGENTS BASED ON MACRO- AND MICROELEMENT-CONTAINING POLYGALACTURONATES (OPTIONS) | 2022 |
|
RU2792613C1 |
| METHOD FOR INCREASING THE LEVEL OF HEMOGLOBIN IN THE BLOOD IN A PATIENT WITH CANCER | 2019 |
|
RU2773153C1 |
| THERAPEUTIC AGENT CONTAINING SODIUM AND CALCIUM IONS, FOR TREATING CANCER, TUMOUR AND NONMALIGNANT HYPERPLASIA | 2012 |
|
RU2600166C2 |
| CANCER CELL APOPTOSIS | 2010 |
|
RU2592230C2 |
| AGENT POSSESSING CHOLESTEROL-REGULATING ACTION | 2007 |
|
RU2352331C1 |
| OLIGONUCLEOTIDE DOSING | 2006 |
|
RU2427377C2 |
| METHOD FOR TREATING PRELIMINARY PATHOLOGICAL PERIOD CASES | 2004 |
|
RU2292883C2 |
| SODIUM COBALT POLYGALACTURONATE WITH ANTITUMOR ACTIVITY | 2023 |
|
RU2794885C1 |
| METHOD OF NEOADJUVANT TREATMENT OF PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER | 2017 |
|
RU2648642C1 |
| 3,3'-DIINDOLYLMETHANE (METINDOL)-BASE VAGINAL SUPPOSITORY | 2006 |
|
RU2318510C1 |
